1. Home
  2. EDSA vs ECDA Comparison

EDSA vs ECDA Comparison

Compare EDSA & ECDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • ECDA
  • Stock Information
  • Founded
  • EDSA 2015
  • ECDA 2013
  • Country
  • EDSA Canada
  • ECDA United States
  • Employees
  • EDSA N/A
  • ECDA N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • ECDA Auto Manufacturing
  • Sector
  • EDSA Health Care
  • ECDA Consumer Discretionary
  • Exchange
  • EDSA Nasdaq
  • ECDA Nasdaq
  • Market Cap
  • EDSA 13.8M
  • ECDA 11.5M
  • IPO Year
  • EDSA N/A
  • ECDA N/A
  • Fundamental
  • Price
  • EDSA $2.03
  • ECDA $0.26
  • Analyst Decision
  • EDSA Strong Buy
  • ECDA
  • Analyst Count
  • EDSA 2
  • ECDA 0
  • Target Price
  • EDSA $13.00
  • ECDA N/A
  • AVG Volume (30 Days)
  • EDSA 33.4K
  • ECDA 13.2M
  • Earning Date
  • EDSA 08-08-2025
  • ECDA 08-18-2025
  • Dividend Yield
  • EDSA N/A
  • ECDA N/A
  • EPS Growth
  • EDSA N/A
  • ECDA N/A
  • EPS
  • EDSA N/A
  • ECDA N/A
  • Revenue
  • EDSA N/A
  • ECDA $24,597,358.00
  • Revenue This Year
  • EDSA N/A
  • ECDA $21.59
  • Revenue Next Year
  • EDSA N/A
  • ECDA N/A
  • P/E Ratio
  • EDSA N/A
  • ECDA N/A
  • Revenue Growth
  • EDSA N/A
  • ECDA 3.46
  • 52 Week Low
  • EDSA $1.55
  • ECDA $0.24
  • 52 Week High
  • EDSA $5.59
  • ECDA $1.35
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 52.89
  • ECDA 36.50
  • Support Level
  • EDSA $1.91
  • ECDA $0.29
  • Resistance Level
  • EDSA $2.14
  • ECDA $0.73
  • Average True Range (ATR)
  • EDSA 0.12
  • ECDA 0.06
  • MACD
  • EDSA 0.02
  • ECDA -0.00
  • Stochastic Oscillator
  • EDSA 64.52
  • ECDA 0.40

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About ECDA ECD Automotive Design Inc.

ECD Automotive Design Inc is a custom-car builder in the Restomod sector with a focus on British classic motor vehicles of various models of both two-door and four-door styles. The company has established a facility geared towards producing the majority customized Land Rovers with the highest quality of parts and the highest quality labor force building each vehicle. ECD restores Land Rovers Defenders, Land Rover Series IIA, the Range Rover Classic and the Jaguar E-Type. It upgrade any engine, including Chevrolet V8's, Land Rover V8's, Cummins diesel engines and new electric drivetrains, performing all the necessary body work, drivetrain selection and installation, every stitch in the interior, paint work, up to placement of the last nut and bolt.

Share on Social Networks: